NCT04030273

Brief Summary

Uterine fibroids are the most common benign tumors of the genital organs of women of childbearing age. Literature data show that more than 75% of women have fibroids.Symptomatic fibroids account for approximately over 200,000 hysterectomies and 50,000 myomectomies annually in the United States. Fibroids have a major impact on fertility, with significant adverse effect on implantation rate and spontaneous abortion rates when compared with infertile women without fibroids. The definitive treatment for uterine fibroids in a fertile patient is surgical excision. Although usually effective, myomectomy is not a risk-free operation, since the surgical procedure can cause mechanical infertility and can be associated with infection, injury to adjacent tissues, hemorrhage and need to convert to hysterectomy. A not often mentioned consequence of myomectomy is post-operative intrauterine adhesion formation. It has been reported that 50% of women undergoing open myomectomy are found to have intrauterine adhesions diagnosed by hysteroscopy performed 3 months after surgery. Such a high prevalence of intrauterine adhesions after open myomectomy is unexpected, however only few studies have addressed this topic. It is accepted that injury to the endometrium is generally considered to be the primary causative factor for the development of intrauterine adhesions. The reason for such a high incidence of intrauterine adhesions after open myomectomy is unclear. It is speculated that infection or in adverted closure of the uterine cavity may play a role in intrauterine adhesion formation. The relationship between the number of fibroids removed and the risk of adhesions suggests a traumatic etiology. In the preservation of the uterus for the purpose of fertility, it is essential to also understand the impact of myomectomy on the endometrium. Currently no guideline recommends in office hysteroscopy as follow-up after myomectomy. The purpose of the present study is to evaluate the frequency of uterine adhesions following myomectomy and the impact of number, size and location of the fibroids as well as intraoperative breach of the endometrial cavity at the time of the myomectomy.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 23, 2019

Completed
2.4 years until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

September 30, 2021

Status Verified

September 1, 2021

Enrollment Period

1 year

First QC Date

July 19, 2019

Last Update Submit

September 28, 2021

Conditions

Keywords

Intrauterine adhesionsAbdominal myomectomyHysteroscopy

Outcome Measures

Primary Outcomes (1)

  • Intrauterine adhesions

    Presence of intrauterine adhesion, following the American Fertility Society classification (Fertil Steril. 1988;49:944-955.) in mild, moderate, or severe.

    3 months after myomectomy

Study Arms (3)

Open (laparotomic) myomectomy

Women undergoing uterine myomectomy by open surgery (laparotomy).

Diagnostic Test: Diagnostic hysteroscopy

Laparoscopic myomectomy

Women undergoing uterine myomectomy by laparoscopy.

Diagnostic Test: Diagnostic hysteroscopy

Robotic myomectomy

Women undergoing uterine myomectomy by robotic surgery.

Diagnostic Test: Diagnostic hysteroscopy

Interventions

Diagnostic hysteroscopy performed in outpatient setting, using "no touch" vaginoscopy technique with a 2.9 mm 30-degree rigid hysteroscope with a single inflow sheet using normal saline as distention media.

Laparoscopic myomectomyOpen (laparotomic) myomectomyRobotic myomectomy

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Female patients from 18 to 45 years of age with the diagnosis of uterine fibroids, wish to preserve fertility/uterus, not candidates for hysteroscopic myomectomy who are scheduled to undergo laparoscopic, robotic assisted or open myomectomy.

You may qualify if:

  • Diagnosis of one or more uterine myomas
  • Desire to preserve fertility/uterus
  • Myomectomy (by laparotomy, laparoscopy or robotic approach).

You may not qualify if:

  • Adults unable to consent
  • Pregnant women
  • Prisoners
  • History of previous intrauterine procedures such as dilation and curettage
  • History of known intrauterine adhesions
  • History of documented pelvic inflammatory disease
  • History of endometritis (acute or chronic)
  • Hysteroscopic myomectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Lagana AS, Garzon S, Dababou S, Uccella S, Medvediev M, Pokrovenko D, Babunashvili EL, Buyanova SN, Schukina NA, Shcherbatykh Kaschchuk MG, Kosmas I, Licchelli M, Panese G, Tinelli A. Prevalence of Intrauterine Adhesions after Myomectomy: A Prospective Multicenter Observational Study. Gynecol Obstet Invest. 2022;87(1):62-69. doi: 10.1159/000522583. Epub 2022 Feb 15.

MeSH Terms

Conditions

MyofibromaGynatresia

Interventions

Hysteroscopy

Condition Hierarchy (Ancestors)

Neoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsConnective Tissue DiseasesSkin and Connective Tissue DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Obstetrical and GynecologicalDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeObstetric Surgical ProceduresGynecologic Surgical ProceduresUrogenital Surgical Procedures

Study Officials

  • Jose Carugno

    University of Miami

    STUDY DIRECTOR
  • Andrea Tinelli

    Vito Fazzi Hospital

    STUDY CHAIR
  • Antonio Simone Laganà

    Università degli Studi dell'Insubria

    STUDY CHAIR

Central Study Contacts

Antonio Simone Laganà, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 19, 2019

First Posted

July 23, 2019

Study Start

January 1, 2022

Primary Completion

January 1, 2023

Study Completion

January 1, 2024

Last Updated

September 30, 2021

Record last verified: 2021-09